Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction

BMC Urology

Volumn 14, Issue 1, 2014, Pages

  Knüpfer, Stephanie C ^a   Liechti, Martina D ^a   Mordasini, Livio ^b   Abt, Dominik ^b   Engeler, Daniel S ^b   Wöllner, Jens ^c   Pannek, Jürgen ^c   Kiss, Bernhard ^d   Burkhard, Fiona C ^d   Schneider, Marc P ^a   Miramontes, Elena ^a   Kessels, Alfons G ^e   Bachmann, Lucas M ^f   Kessler, Thomas M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

^c SWISS PARAPLEGIC RESEARCH   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MEDIGNITION INC   (Switzerland)

Author keywords

Double blind trial; Neurogenic lower urinary tract dysfunction; Placebo controlled; Randomized; Sacral neuromodulation; Urinary bladder

Indexed keywords

PLACEBO;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; IMPLANTABLE NEUROSTIMULATOR; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE PROCEDURE; MULTICENTER STUDY; NEUROGENIC BLADDER; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SACRAL NERVE STIMULATION; SWITZERLAND; URINE INCONTINENCE; UROLOGIC EXAMINATION; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; BACK; CLINICAL TRIAL; ELECTRODE IMPLANT; ELECTROSTIMULATION THERAPY; METHODOLOGY; PATIENT SELECTION; PROCEDURES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC;

ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; PATIENT SELECTION; PROSPECTIVE STUDIES; RESEARCH DESIGN; SACROCOCCYGEAL REGION; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC;

EID: 84908271707     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-14-65     Document Type: Article

References (18)

1. Surgery illustrated-surgical atlas sacral neuromodulation. Wöllner J, Hampel C, Kessler TM, BJU Int 2012 110 1 146 159
2. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. Brazzelli M, Murray A, Fraser C, J Urol 2006 175 3 Pt 1 835 841
3. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, Chancellor MB, Richard F, Denys P, J Urol 2000 164 5 1476 1480
4. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Herbison GP, Arnold EP, Cochrane Database Syst Rev 2009 2 CD004202
5. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Kessler TM, Buchser E, Meyer S, Engeler DS, Al-Khodairy AW, Bersch U, Iselin CE, Roche B, Schmid DM, Schurch B, Zrehen S, Burkhard FC, Eur Urol 2007 51 5 1357 1363
6. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama a Nijholt AA, Siegel S, Jonas U, Fowler CJ, Fall M, Gajewski JB, Hassouna MM, Cappellano F, Elhilali MM, Milam DF, Das AK, Dijkema HE, van den Hombergh U, J Urol 2007 178 5 2029 2034
7. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, et al. Neurourol Urodyn 2010 29 1 213 240
8. Sacral nerve neuromodulation in patients with underlying neurologic disease. Wallace PA, Lane FL, Noblett KL, Am J Obstet Gynecol 2007 197 1 96 e91-95
9. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, Schurch B, Sievert KD, Engeler DS, Eur Urol 2010 58 6 865 874
10. Is one question enough to detect female sexual dysfunctions? A diagnostic accuracy study in 6,194 women. Kriston L, Gunzler C, Rohde A, Berner MM, J Sex Med 2010 7 5 1831 1841
11. Confirmatory factor analysis of the German version of the international index of erectile function (IIEF): a comparison of four models. Kriston L, Gunzler C, Harms A, Berner M, J Sex Med 2008 5 1 92 99
12. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, Amarenco G, Espirac B, Leriche A, Eur Urol 2001 39 1 107 113
13. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Association WM, JAMA 2013 310 20 2191 2194
14. International conference on harmonisation, Good clinical practice guideline 1996 [ http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html ]
15. Swiss Academy of Medical Sciences, Guideline-Concerning scientific research involving human beings 2009 [ http://www.samw.ch/dms/de/Publikationen/Leitfaden/d-Forschung-mit-Menschen.pdf ]
16. The Federal Authorities of the Swiss Confederation, Bundesgesetz über den Datenschutz (DSG) vom 19. Juni 1992 1992 [ http://www.admin.ch/ch/d/sr/2/235.1.de.pdf ]
17. Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Groen J, Karsenty G, Kessler TM, Kramer G, Stöhrer M, EAU guidelines on neuro-urology 2014 [ http://www.uroweb.org/gls/pdf/21%20Neuro-Urology-LR.pdf ]
18. Botulinum toxin injections into the detrusor. Wöllner J, Kessler TM, BJU Int 2011 108 9 1528 1537